Dietary Supplement Compliance Attorney Serving Sweetwater

Sweetwater — the Dolphin Expressway trade corridor beside Florida International University, gateway to west Dade’s warehouse districts — keeps a dietary supplement compliance attorney busier than almost anywhere in America. Sweetwater sits directly on the Dolphin Expressway trade corridor, sandwiched between Florida International University and the warehouse districts that serve the airport. Its business community runs on the import economy — distribution operators, consumer-product importers and supplement and personal-care companies moving goods from MIA’s cargo gates to the rest of the country. For Sweetwater’s import-driven businesses, FDA compliance is not a corporate abstraction — it is whether this week’s containers clear.

Quick answer

Supplements live under DSHEA’s bargain: no pre-approval, but strict rules on ingredients, claims, manufacturing and labeling — and aggressive FDA enforcement at the border and in the market when brands overstep. Compliance work means keeping ingredients lawful, claims substantiated and cGMP records inspection-ready.

Why this matters now

Supplements draw disproportionate FDA and FTC attention — disease-claim warning letters arrive in waves, import alerts cover whole ingredient classes, and cGMP inspection failures halt production. For brands built on a hero ingredient, one adverse regulatory finding can take the flagship product off the market.

The rules in plain terms

The Dietary Supplement Health and Education Act (DSHEA) lets supplements reach market without pre-approval, but the conditions are real: ingredients must be lawful dietary ingredients — with new dietary ingredient (NDI) notifications for those not marketed before 1994 — manufacturing must meet the cGMP rule at 21 CFR Part 111, and labels must carry the Supplement Facts panel and required disclaimers.

Claims are the classic trap. Structure/function claims (“supports immune health”) are permitted with substantiation, notification to FDA and the DSHEA disclaimer; disease claims (“treats,” “cures,” “prevents”) convert the product into an unapproved drug instantly — a favorite basis for warning letters, import refusals and injunctions. Website copy, social media and influencer posts all count as labeling.

Importers face a second front: supplement ingredients and finished products are heavily screened, several appear on import alerts, and FDA detains shipments over unlisted facilities, adulteration concerns and drug claims on labels. Adverse event reporting obligations for serious events round out the regime.

How the process works

Ingredient review: dietary-ingredient status, NDI analysis, and the additive/GRAS questions for combination products
Claims audit across labels, websites and marketing — substantiation files and disease-claim scrubbing
cGMP program review against 21 CFR Part 111: specifications, testing, batch records, qualified personnel
Import strategy for ingredients and finished goods — entry data, supplier documentation, alert management
Enforcement response: 483s, warning letters, detentions and the corrective packages that resolve them

Serving Sweetwater from Brickell

The work around Sweetwater — warehouse and distribution operators, consumer product importers, cosmetics and personal care distribution, dietary supplement companies, university-linked ventures — is FDA-regulated at nearly every turn, and matters here move on the Dolphin Expressway trade corridor beside Florida International University, gateway to west Dade’s warehouse districts. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.

Best practices — and common mistakes

Letting marketing write disease claims the regulatory file cannot support
Launching an ingredient that needed an NDI notification nobody filed
Relying on a contract manufacturer’s cGMP without your own specifications and oversight — the brand owns compliance too
Ignoring what the website and social accounts say, as if only the bottle were the label
Importing ingredients from suppliers already on import alert

Frequently asked questions

Do dietary supplements need FDA approval?

No pre-market approval — but that is not deregulation. Ingredients must qualify as dietary ingredients (with NDI notifications where required), manufacturing must meet Part 111 cGMPs, labels must be compliant, and claims must stay on the structure/function side of the line. FDA enforces all of it after market entry and at the border.

What claims can a supplement legally make?

Structure/function claims about normal body function, with substantiation, a 30-day notification to FDA and the DSHEA disclaimer. Claims to diagnose, treat, cure or prevent disease are drug claims — the fastest route to a warning letter or an import refusal that exists in this industry.

What is an NDI notification and do I need one?

A new dietary ingredient — one not marketed in the U.S. before October 15, 1994 — generally requires a safety notification to FDA 75 days before marketing. Skipping it renders the product adulterated. Whether your ingredient needs one is a factual and legal analysis worth doing before launch, not after a warning letter.

Why was my supplement shipment detained at the port?

Common bases: labels bearing disease claims, unregistered or unverifiable facilities, ingredients on import alert, or adulteration concerns. Supplement entries through Miami are screened hard; the response depends on the specific charge on the Notice of FDA Action.

Does FDA inspect supplement brands or just manufacturers?

Both. Own-label distributors are held to Part 111 obligations they often do not realize they carry — specifications, supplier qualification, complaint files and adverse event records. A brand that cannot produce those records fails an inspection regardless of how good its co-packer is.

Explore related pages

Request a Consultation